Skip to content
Search

Latest Stories

NHS England digital service hits 1M GP surgery registrations milestone

NHS England digital service hits 1M GP surgery registrations milestone
All GP surgeries across England have been asked to offer the Register with a GP surgery service starting from October 2024. 

Over a period of 18 months since its introduction, the NHS England's online GP registration service has garnered over one million users nationwide.

The online Register with a GP surgery service enables patients to easily register with a local GP practice without the need for an in-person visit, eliminating the need for physical paperwork and reducing administrative burdens on GP practice staff. The service offers accessibility in multiple languages, further enhancing its convenience.


One in three GP practices are now using the online tool, consisting of both an online registration platform and an alternative paper form. As per the recently released GP contract, all GP surgeries across England are required to provide the service starting from October 2024.

Primary Care Minister, Andrea Leadsom, reiterated that the NHS is committed to “embracing the latest technology” and this online tool “is a great example of how we are making access to GPs faster, simpler and fairer for patients.”

“Online registration frees up precious time for receptionists, cuts administration workloads and ensures our hard-working GPs and their teams have more time to focus on providing high-quality care to their patients,” she added.

Amidst these advancements, concerns persist regarding prolonged wait times for medical consultations, with more individuals experiencing delays in accessing healthcare services as per several industry reports.

Despite the momentum towards digitalisation, a substantial portion of the population, approximately 6.8 million people, still prefer traditional paper forms. To address this preference, authorities have adopted a dual approach, offering both online registration and complementary paper forms.

Dr Amanda Doyle, National Director of Primary Care and Community Services for NHS England, expressed contentment over reaching the milestone of 1 million online GP registrations, stating that it "shows the value of the service for both patients and GP surgeries."

“We continue to see a steady increase in the number of GP practices coming on board, which is helping them to save both time and money. By recently integrating the service with the NHS App, we hope even more GP practices will take advantage of this new digital tool," she said.

The transition from traditional paper records to Electronic Patient Records (EPR) has emerged as a primary focus of digital transformation within the NHS. With the government's ambitious target for all NHS trusts to adopt an EPR system by March 2025, the healthcare landscape is poised for substantial modernisation.

With this online service, NHS England envisions simplifying registration for both patients and practices thereby, building trust between healthcare providers by helping patients complete the information correctly.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less